Grace Therapeutics, Inc 10-Q for FY2022 Q3
Grace Therapeutics, Inc. (GRCE)
10-Q
2022-02-14
For: 2021-12-31
View Original
Added on
April 11, 2026
About this 10-Q
Grace Therapeutics, Inc filed this 10-Q on February 14, 2022, covering the quarter ended December 31, 2021 (FY2022 Q3).
Headline figures
Quarter ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $81K a year earlier
- Net loss
- $3.78M
- compared with a net loss of $3.22M a year earlier